Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Combination of Fosfomycin plus Meropenem Is Synergistic for Pseudomonas aeruginosa PAO1 in a Hollow-Fiber Infection Model

25 Sept 2018

Abstract excerpt

Treating high-density bacterial infections is a challenging clinical problem. We have a paucity of new agents that can address this problem.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotics Pharmacokinetics and Efficacy
Share to Urinary Tract Infections Management

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30249700
DOI: 10.1128/aac.01682-18

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Combination of Fosfomycin plus Meropenem Is Synergistic for Pseudomonas aeruginosa PAO1 in a Hollow-Fiber Infection ModelPMID 30249700Read ↗

Optimization of a Meropenem-Tobramycin Combination Dosage Regimen against Hypermutable and Nonhypermutable Pseudomonas aeruginosa via Mechanism-Based Modeling and the Hollow-Fiber Infection Model.Semantic proximity Read ↗

Virulence attenuating combination therapy: a potential multi-target synergy approach to treat Pseudomonas aeruginosa infections in cystic fibrosis patientsSemantic proximity Read ↗

Current and novel therapies for management of Acinetobacter baumannii -associated pneumoniaSemantic proximity Read ↗

Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance.Semantic proximity Read ↗

The combination of meropenem and levofloxacin is synergistic with respect to both Pseudomonas aeruginosa kill rate and resistance suppression.Semantic proximity Read ↗

Bacteriophage–Antibiotic Combination Therapy against Pseudomonas aeruginosaSemantic proximity Read ↗

Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case seriesSemantic proximity Read ↗

Evidence for Complex Interplay between Quorum Sensing and Antibiotic Resistance in Pseudomonas aeruginosaSemantic proximity Read ↗

A folate inhibitor exploits metabolic differences in Pseudomonas aeruginosa for narrow-spectrum targetingSemantic proximity Read ↗

Beyond antibiotics: Emerging antivirulence strategies to combat Pseudomonas aeruginosa in cystic fibrosisSemantic proximity Read ↗

Nano-antibiotics combined with laser irradiation to reduce the development of drug resistance of K. Pneumoniae and accelerate wound healingSemantic proximity Read ↗

Meropenem in combination with baicalein exhibits synergism against extensively drug resistant and pan-drug-resistant Acinetobacter baumannii clinical isolates in vitroSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.